Why DexCom Inc’s (DXCM) Stock Is Up 5.44% (2024)

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate DexCom Inc before investing.

In this article, we go over a few key elements for understanding DexCom Inc’s stock price such as:

Before we jump into DexCom Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.

Want to learn more about DexCom Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about DexCom Inc.

As of July 29, 2024, 4:00 PM, CST, DexCom Inc’s stock price was $67.48.

DexCom Inc is up 5.44% from its previous closing price of $64.00.

During the last market session, DexCom Inc’s stock traded between $62.34 and $67.44. Currently, there are 399.20 million shares of DexCom Inc stock available for purchase.

DexCom Inc’s price-earnings (P/E) ratio is currently at 42.2, which is high compared to the Medical Equipment, Supplies & Distribution industry median of 39.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

DexCom Inc’s (DXCM) price is currently down 40.48% so far this month.

During the month of July, DexCom Inc’s stock price has reached a high of $117.19 and a low of $62.34.

Over the last year, DexCom Inc has hit prices as high as $142.00 and as low as $62.34. Year to date, DexCom Inc’s stock is down 40.41%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 26, 2024, there were 19 analysts who downgraded DexCom Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate DexCom Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on DexCom Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

DexCom Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about DexCom Inc (DXCM) by visiting AAII Stock Evaluator.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 26, 2024, DexCom Inc has a weighted four-quarter relative price strength of -22.33%, which translates to a Momentum Score of 14 and is considered to be Very Weak.

Want to learn more about how DexCom Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

As of July 29, 2024, DexCom Inc’s stock price is $67.48, which is up 5.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like DexCom Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.